These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 30586697)

  • 1. Oxidized Low-Density Lipoprotein Receptor in Lymphocytes Prevents Atherosclerosis and Predicts Subclinical Disease.
    Tsilingiri K; de la Fuente H; Relaño M; Sánchez-Díaz R; Rodríguez C; Crespo J; Sánchez-Cabo F; Dopazo A; Alonso-Lebrero JL; Vara A; Vázquez J; Casasnovas JM; Alfonso F; Ibáñez B; Fuster V; Martínez-González J; Martín P; Sánchez-Madrid F
    Circulation; 2019 Jan; 139(2):243-255. PubMed ID: 30586697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resident Memory T Cells in the Atherosclerotic Lesion Associate With Reduced Macrophage Content and Increased Lesion Stability.
    de Jong MJM; Depuydt MAC; Schaftenaar FH; Liu K; Maters D; Wezel A; Smeets HJ; Kuiper J; Bot I; van Gisbergen K; Slütter B
    Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):1318-1329. PubMed ID: 38634281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation.
    Martín P; Gómez M; Lamana A; Cruz-Adalia A; Ramírez-Huesca M; Ursa MA; Yáñez-Mo M; Sánchez-Madrid F
    Mol Cell Biol; 2010 Oct; 30(20):4877-89. PubMed ID: 20696842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD69: an unexpected regulator of TH17 cell-driven inflammatory responses.
    Martín P; Sánchez-Madrid F
    Sci Signal; 2011 Mar; 4(165):pe14. PubMed ID: 21427408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired Autophagy in CD11b
    Clement M; Raffort J; Lareyre F; Tsiantoulas D; Newland S; Lu Y; Masters L; Harrison J; Saveljeva S; Ma MKL; Ozsvar-Kozma M; Lam BYH; Yeo GSH; Binder CJ; Kaser A; Mallat Z
    Circ Res; 2019 Nov; 125(11):1019-1034. PubMed ID: 31610723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive GITR Activation Reduces Atherosclerosis by Promoting Regulatory CD4+ T-Cell Responses-Brief Report.
    Meiler S; Smeets E; Winkels H; Shami A; Pascutti MF; Nolte MA; Beckers L; Weber C; Gerdes N; Lutgens E
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1748-52. PubMed ID: 27444204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells promote the sustained expression of CD69 on activated T lymphocytes: roles of canonical and non-canonical NF-κB signalling.
    Saldanha-Araujo F; Haddad R; Farias KC; Souza Ade P; Palma PV; Araujo AG; Orellana MD; Voltarelli JC; Covas DT; Zago MA; Panepucci RA
    J Cell Mol Med; 2012 Jun; 16(6):1232-44. PubMed ID: 21777379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD69-oxLDL ligand engagement induces Programmed Cell Death 1 (PD-1) expression in human CD4 + T lymphocytes.
    Jiménez-Fernández M; Rodríguez-Sinovas C; Cañes L; Ballester-Servera C; Vara A; Requena S; de la Fuente H; Martínez-González J; Sánchez-Madrid F
    Cell Mol Life Sci; 2022 Aug; 79(8):468. PubMed ID: 35930205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
    Karper JC; de Jager SC; Ewing MM; de Vries MR; Bot I; van Santbrink PJ; Redeker A; Mallat Z; Binder CJ; Arens R; Jukema JW; Kuiper J; Quax PH
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2810-7. PubMed ID: 24115036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice.
    Foks AC; Engelbertsen D; Kuperwaser F; Alberts-Grill N; Gonen A; Witztum JL; Lederer J; Jarolim P; DeKruyff RH; Freeman GJ; Lichtman AH
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):456-65. PubMed ID: 26821944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented Th17 differentiation in Trim21 deficiency promotes a stable phenotype of atherosclerotic plaques with high collagen content.
    Brauner S; Jiang X; Thorlacius GE; Lundberg AM; Östberg T; Yan ZQ; Kuchroo VK; Hansson GK; Wahren-Herlenius M
    Cardiovasc Res; 2018 Jan; 114(1):158-167. PubMed ID: 29016728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD69 overexpression by human T-cell leukemia virus type 1 Tax transactivation.
    Ishikawa C; Kawakami H; Uchihara JN; Senba M; Mori N
    Biochim Biophys Acta; 2013 Jun; 1833(6):1542-52. PubMed ID: 23507197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherosclerosis development in apolipoprotein E-null mice deficient for CD69.
    Gómez M; Sanz-González SM; Abu Nabah YN; Lamana A; Sánchez-Madrid F; Andrés V
    Cardiovasc Res; 2009 Jan; 81(1):197-205. PubMed ID: 18703531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.
    Radulovic K; Manta C; Rossini V; Holzmann K; Kestler HA; Wegenka UM; Nakayama T; Niess JH
    J Immunol; 2012 Feb; 188(4):2001-13. PubMed ID: 22250092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
    Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
    J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD69 Plays a Beneficial Role in Ischemic Stroke by Dampening Endothelial Activation.
    Brait VH; Miró-Mur F; Pérez-de-Puig I; Notario L; Hurtado B; Pedragosa J; Gallizioli M; Jiménez-Altayó F; Arbaizar-Rovirosa M; Otxoa-de-Amezaga A; Monteagudo J; Ferrer-Ferrer M; de la Rosa X; Bonfill-Teixidor E; Salas-Perdomo A; Hernández-Vidal A; Garcia-de-Frutos P; Lauzurica P; Planas AM
    Circ Res; 2019 Jan; 124(2):279-291. PubMed ID: 30582456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD69 autoantibodies cross-react with low density lipoprotein receptor-related protein 2 in systemic autoimmune diseases.
    Yu X; Matsui T; Otsuka M; Sekine T; Yamamoto K; Nishioka K; Kato T
    J Immunol; 2001 Jan; 166(2):1360-9. PubMed ID: 11145721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGB1Modulates the Treg/Th17 Ratio in Atherosclerotic Patients.
    Ding JW; Zheng XX; Zhou T; Tong XH; Luo CY; Wang XA
    J Atheroscler Thromb; 2016 Jun; 23(6):737-45. PubMed ID: 26830200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
    Butcher MJ; Waseem TC; Galkina EV
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
    Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.